| Reduction Of Frown Lines - Mentor Corporation Announces Completion Of PurTox(R) 3A Study Mentor Corporation (NYSE:MNT), a leading supplier of medical products for the global aesthetic market, today announced completion of the first of three Phase 3 clinical trials with its purified botulinum Type A neurotoxin (PurTox®) for the reduction of glabellar rhytides (frown lines). This newly completed study involved 400 subjects at ten investigational sites in the United States. Subjects received a single treatment with PurTox or placebo. medicalnewstoday.com |
Candela Receives Registration Approval To Market The Alex TriVantage Laser In Brazil Candela Corporation (NASDAQ:CLZR) announced that it has received registration approval from the Brazilian National Health Surveillance Agency (ANVISA) to market the Candela Alex TriVantage® multi-wavelength, q-switched laser system in Brazil. "Until now, providing high quality and effective treatment for pigmented lesions and multi-color tattoos meant that Brazilian doctors needed to own at least two different lasers. medicalnewstoday.com |
American Society Of Plastic Surgeons Hosts 78th Annual Meeting Whether in a quest for beauty or out of necessity, millions of Americans will have plastic surgery this year. To stay ahead of the demand, the hottest topics, technologies, and research will be presented at Plastic Surgery 2009, the annual scientific meeting of the American Society of Plastic Surgeons (ASPS), Oct. 23-27, in Seattle. medicalnewstoday.com |
Skin Deep: Beauty Spots Beauty Spots. nytimes.com |
Unilever to Buy Alberto Culver for $3.7 Billion Unilever said the deal would make it the top company in hair conditioning and put it in the top three for shampoo and styling products. nytimes.com |